KANEKA PHARMA AMERICA XPRESS-WAY RX— 510(k) K101839

Substantially Equivalent

Kaneka Pharma America, LLC

FDA 510(k) clearance K101839 for KANEKA PHARMA AMERICA XPRESS-WAY RX, Substantially Equivalent on 2010-10-22. Applicant: Kaneka Pharma America, LLC.

Clearance details

Applicant: Kaneka Pharma America, LLC
Product code: Code QEZ
Advisory panel: Cardiovascular
Date received: 2010-07-01
Decision date: 2010-10-22
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Hudson, NH, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code QEZ

product code QEZ

Death: 24
Total: 24

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.